comparemela.com

Latest Breaking News On - Liver cancer study - Page 1 : comparemela.com

Can-Fite Reports Second Quarter 2023 Financial Results & Progress in Two Pivotal Phase III Clinical Studies

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory and liver diseases, today announced financial results.

Russia
Italy
Ukraine
United-states
Israel
American
Russian
Pnina-fishman
Motti-farbstein
European-medicines-agency
American-society-of-clinical-oncology
Telethon-institute-of-genetics

VA to launch large study on liver cancer early detection

Veterans are at a slightly higher risk than the general population for liver disease because of risk factors like hepatitis C, diabetes and hypertension.

George-ioannou
Tamar-taddei
Department-of-veterans-affairs
Veterans-affairs
Va-liver-cancer
Liver-cancer-study
Studying-liver-cancer

VA to launch large study on liver cancer early detection

Veterans are at a slightly higher risk than the general population for liver disease because of risk factors like hepatitis C, diabetes and hypertension.

George-ioannou
Tamar-taddei
Department-of-veterans-affairs
Veterans-affairs
Va-liver-cancer
Liver-cancer-study
Studying-liver-cancer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.